Quantcast

Latest Opioid dependence Stories

2014-09-22 14:14:40

Methadone has been used to treat opiate addiction in America for about 50 years, since Dr. Vincent Dole of New York’s Rockefeller University first discovered that the drug was able to relieve opiate withdrawal symptoms and allow addicts to return to their normal lives. Although numerous studies support the safety and efficacy of methadone maintenance for the treatment of opiate addiction, myths about methadone continue to thrive. If you or someone close to you is struggling with opiate...

2014-09-16 08:32:01

Big Cities Health Coalition Urges Immediate Federal Action WASHINGTON, Sept. 16, 2014 /PRNewswire/ -- Today, the top public health officials from Boston, Chicago, and New York City, all members of the Big Cities Health Coalition, arrived on Capitol Hill with a grim report on the state of opioid addiction and overdose in our nation's cities - and a request for federal action to be taken immediately. "Opioid addiction is one of the most challenging problems for health departments to...

2014-09-11 23:05:13

Millennium Treatment Group will treat patients from New Jersey who are battling heroin addiction, which has become a full-blown epidemic in the Garden State. Lake Worth, FL (PRWEB) September 11, 2014 New Jersey is in the midst of a full-blown heroin crisis. According to the New Jersey Attorney General, there were 449 overdose deaths from heroin and morphine in 2012, 591 deaths in 2013 and 380 deaths in the first six months of 2014. While Millennium Treatment Group is located in Florida,...

2014-09-03 08:32:49

September 4th ceremony celebrates 2014 accomplishments including FDA approval and anticipated commercial launch of BUNAVAIL RALEIGH, N.C., Sept. 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will visit the NASDAQ MarketSite in Times Square on September 4, 2014. In honor of the occasion, Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will ring the opening bell for the trading session that day....

2014-08-27 08:27:45

RALEIGH, N.C., Aug. 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will be hosting an investor and analyst event and simultaneous webcast on Friday, September 5, 2014. The event is scheduled for 12-2 pm ET in New York City. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO At this event, BDSI senior management will discuss the commercialization and launch plan for BUNAVAIL and provide updates on the BEMA(®)...

2014-08-12 08:29:19

BEMA Buprenorphine on track for late 2014 or early 2015 NDA filing by partner Endo Pharmaceuticals RALEIGH, N.C., Aug. 12, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that along with its commercial partner, Endo Pharmaceuticals, engaged in a positive pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) regarding BEMA Buprenorphine for the management of pain severe enough to require daily, around-the-clock,...

2014-08-07 16:29:42

BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) approved by FDA for the maintenance treatment of opioid dependence; US launch planned for late Q3 RALEIGH, N.C., Aug. 7, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent achievements and an...

2014-07-22 12:29:33

PITTSBURGH, July 22, 2014 /PRNewswire/ -- Community Care Behavioral Health Organization today released guidelines for treatment and recovery practices involving the use of methadone, an opioid used to treat opioid addiction. The guidelines* - titled, "Supporting Recovery from Opioid Addiction: Community Care Best Practice Guidelines for Recovery-Oriented Methadone Maintenance" - are intended to provide direction for physicians, clinicians, agencies, and systems in the Community Care...

2014-07-22 08:31:15

RALEIGH, N.C., July 22, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr. Barry I. Feinberg as members of the Board. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO Mr. Bramlage is a veteran pharmaceutical industry executive with extensive experience in marketing, sales and other commercial functions. He is currently the Chief Executive Officer of...

2014-07-16 08:28:03

FDA also approves the use of two Butrans patches for dose adjustments in appropriate chronic pain patients STAMFORD, Conn., July 16, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) approved a new 7.5 mcg/hour dosage strength of Butrans(®) (buprenorphine) Transdermal System CIII. Five strengths of Butrans will now be available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour. The Butrans Transdermal System is also...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related